Bank Of New York Mellon Corp Talis Biomedical Corp Transaction History

Bank Of New York Mellon Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.81 - $1.44 $42,494 - $75,545	-52,462 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$1.3 - $4.19 $2,709 - $8,731	-2,084 Reduced 3.82%	52,462 $74,000
Q4 2021 Feb 11, 2022	SELL	$3.81 - $6.17 $126,873 - $205,461	-33,300 Reduced 37.91%	54,546 $219,000
Q3 2021 Nov 12, 2021	BUY	$6.02 - $12.46 $17,235 - $35,672	2,863 Added 3.37%	87,846 $550,000
Q2 2021 Aug 11, 2021	BUY	$9.62 - $14.56 $48,504 - $73,411	5,042 Added 6.31%	84,983 $937,000
Q1 2021 May 13, 2021	BUY	$11.2 - $27.8 $895,339 - $2.22 Million	79,941 New	79,941 $1.03 Million

Ticker TLIS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 26,619,200
Market Cap $47.1M
Description
Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.